| Price Range 12mo avg: | $940K – $6.3M |
|---|---|
| $/sf 12mo avg: | $376 |
| CAP Rate 12mo avg: | 6.87% |
| NOI average: | $193,167 |
| Lease Terms: | 15yrs NN |
| Building Size avg: | 8,000 SF |
| Lot Size avg: | 0.75+/- acres |
DaVita Kidney Care is a division of DaVita HealthCare Partners Inc., a Fortune 500® company that, through its operating divisions, provides a variety of health care services to patient populations throughout the United States and abroad. A leading provider of dialysis services in the United States, DaVita Kidney Care treats patients with chronic kidney failure and end stage renal disease. DaVita Kidney Care strives to improve patients’ quality of life by innovating clinical care, and by offering integrated treatment plans, personalized care teams and convenient health management services. As of September 30, 2015, DaVita Kidney Care operated or provided administrative services at 2,225 outpatient dialysis centers located in the United States serving approximately 177,000 patients. The company also operated 104 outpatient dialysis centers located in 10 countries outside the United States. DaVita Kidney Care supports numerous programs dedicated to creating positive, sustainable change in communities around the world. The company’s leadership development initiatives and social responsibility efforts have been recognized by Fortune, Modern Healthcare, Newsweek and WorldBlu.
DaVita—which is Italian for “giving life”—has more than 50,000 teammates (employees) around the nation working to provide superior patient care and exemplify the company’s Core Values
| S&P Credit Rating: | BB- |
|---|---|
| Moody’s Credit Rating: | Ba3 |
| Annual Revenue 2014: | $12.8B |
| Annual Revenue 2013: | $11.8B |
| Revenue Growth: | ↑ 8.13% from 2013 |
| Net Income | $723M |
| Units (Dec. 2014) | 2,179 |
| Average Units Volume: | $331856K |
Yahoo! Finance: DVA News Latest Financial News for DVA
-
DaVita Inc. Announces Pricing of $1.5 Billion Senior Notes Offering
on August 6, 2020 at 10:01 pm
DaVita Inc. (NYSE: DVA) ("DaVita") announced today the pricing of its previously announced private offering of $1.5 billion aggregate principal amount of senior notes due 2031 (the "2031 notes"). The 2031 notes were priced at 100% of their face amount to yield a 3.750% coupon. The offering is expected to close on August 11, 2020, subject to satisfaction of customary closing conditions. […]
-
The Zacks Analyst Blog Highlights: DaVita, PayPal, Century Communities, Berry Global and Turning Point Brands
on August 6, 2020 at 1:27 pm
The Zacks Analyst Blog Highlights: DaVita, PayPal, Century Communities, Berry Global and Turning Point Brands […]
-
DaVita Inc. -- Moody's assigns Ba3 rating to DaVita's new unsecured notes
on August 6, 2020 at 1:15 pm
Moody's Investors Service ("Moody's") announced today that it assigned a Ba3 rating to DaVita Inc.'s ("DaVita") proposed senior unsecured global notes due 2031. There is no change to DaVita's existing ratings, including its Ba2 Corporate Family Rating (CFR), Ba2-PD Probability of Default Rating, Ba1 senior secured rating, and Ba3 unsecured rating. […]
-
DaVita Inc. Announces Offering of $1.5 Billion Senior Notes
on August 6, 2020 at 11:27 am
DaVita Inc. (NYSE: DVA) ("DaVita") announced today that it has commenced a private offering of $1.5 billion aggregate principal amount of senior notes due 2031 (the "2031 notes"), subject to market and other conditions. […]
-
Is DaVita HealthCare (DVA) a Great Value Stock Right Now?
on August 4, 2020 at 3:50 pm
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. […]
NYSE: DVA
